SBIR Phase II: High-Throughput and Scalable Nanoparticle Characterization for Life Sciences Applications08/15/2018 - 07/31/2020 (PI)
Nanoview Diagnostics Inc. National Science FdnIIP-1831192
Genetic probing of residues involved in ebolavirus glycoprotein entry07/01/2018 - 06/30/2020 (PI)
NIH/National Institute of Allergy & Infectious Diseases1R21AI135517-01
role for polyamines in Ebola Virus Replication02/01/2016 - 01/31/2019 (PI)
NIH/National Institute of Allergy & Infectious Diseases5R21AI121933-02
Assessment of infection route and vulnerability of neural precursor classes to Zika virus09/30/2016 - 08/31/2018 (Co-PI)
PI:
Tarik Haydar, PhDNIH/National Institute of Neurological Disorders & Stroke5R21NS101151-02
Development of Near Real-Time, Multiplexed Diagnostics for Viral Hemorrhagic Fever08/01/2011 - 07/31/2018 (PI)
NIH/National Institute of Allergy & Infectious Diseases5R01AI096159-05
Elimination of pathogenic IgE in cystic fribrosis08/01/2016 - 05/01/2018 (PI)
The Brigham and Women's Hospital, Inc. NIH NHLBI5U54HL119145-05
Inclusivity and Exclusivity Testing of advanced assays for fever of unknown origin04/13/2017 - 04/12/2018 (PI)
Becton, Dickinson and Company DOD Naval Res Lab
Point-of-Care Nanotechnology Diagnostic for Differential Fever Diagnosis10/01/2015 - 10/31/2017 (PI)
Becton, Dickinson and Company Paul G. Allen Fdn
Biomarker Discovery03/10/2015 - 02/28/2017 (PI)
Johns Hopkins University Applied Physics Laboratory LLC, The Ntl Intel - IARPA
I/UCRC Collaborative Research07/01/2011 - 02/28/2017 (SP Co-PI of Sub-Project / SP)
I/UCRC: Industry Memberships
Showing 10 of 18 results.
Show All Results
Evaluation of the mechanism of action of FDA-approved compounds that show activity against ebolavirus08/18/2014 - 02/17/2017 (PI)
Department of Defense/Army Medical Research Acquisition Activity
Elimination of pathogenic IgE in cystic fribrosis02/01/2016 - 10/31/2016 (PI)
The Brigham and Women's Hospital, Inc. NIH NHLBI4U54HL119145-04
Combined Viral Load and Serology Panel for Rapid POC Ebola Diagnostics03/01/2015 - 02/29/2016 (PI)
Nexgen Arrays LLC NIH NIAID1R43AI1185254-01
Stage-Specific Inhibitors of Orthopoxviruses04/15/2011 - 03/31/2014 (PI)
NIH/National Institute of Mental Health5R03MH094169-02
Development and Characterization of Animal Models for Filoviruses02/15/2010 - 12/31/2013 (PI)
Department of Defense/Army
Microarray Processing and Analysis of Biological Samples from Non-Human Primate Models of Viral Infections and Human Clinical Samples Supporting USAMRID Grant: Identification of Biomarkers12/30/2010 - 12/29/2012 (PI)
Harvard University DOD ARL
Control of the eIF4F Complex by Vesicular Stomatitis Virus08/01/2006 - 07/31/2009 (PI)
NIH/National Institute of Allergy & Infectious Diseases5 K22 AI64606 02
Proof of Concept Studies on a Class of Broad Spectrum Antiviral Components03/01/2008 - 02/28/2009 (PI)
Harvard University NIH NIAID